This study was undertaken to assess the effect of extracorporeal oxygenation on the heart and on gas exchange. In acute experiments on anesthetized, closedchest greyhounds, venovenous shunting under pulsatile pressure did not affect heart rate, cardiac output or arterial blood pressure. Then progressive hypoxia was produced by hypoventilation and the venous oxygen tension was raised by mechanical oxygenation. The magnitude of this effect was inversely related to the degree of existing hypoxia. With the blood flow from a single cannula in a femoral vein and with an efficient oxygenator, a volume of oxygen amounting to half of the animal's consumption could be transferred.
ompared with the difficulty in assessing the benefit of assisted circulation in heart failure, the proposition to use oxygenating devices in respiratory failure is simple and obvious. Therefore, it is not surprising that the investigators who designed screen,' disc,' bubble:' and membrane oxygenators4 almost two decades ago envisaged their first application in pulmonary insufficiency rather than in open heart surgery. Thus, one year before the first open cardiotomy under total cardiopulmonary bypass, the only well-documented clinical use of extracorporeal oxygenation in respiratory failure was described.Vor 75 minutes 1,300 ml of venous blood from a saphenous vein were drained into an oxygenator and pumped back into an antecubital vein. During perfusion the patient's cyanosis, dys- pnea and orthopnea were relieved and the arterial oxygen saturation, carbon dioxide content and hydrogen ion concentration improved. Because of chronic pulmonary fibrosis the relief was only temporary. Since then investigators have explored the feasibility of prolonged oxygenation of venous blood, but excessive trauma to the blood and damage to the lungs($-8 prohibited human applications. Though it has been known for a long time that the damage to the blood cells and the lipoproteins of the plasma is caused by the open gas-toliquid interface, the industrial development of a separating, thin, sturdy and leakproof polycarbonate-silicone membrane is a recent development." This has led to improved design and efficiency of membrane oxygenators which make atraumatic oxygenation for many days possible.10-11 Thus, extracorporeal support of patients with pulmonary insufficiency holds more promise in the near future than in the preceding two decades. Because the variability of hypoxia, rate of flow, cardiac output and the oxygenating capacity of the various devices used precluded an evaluation of the efficacy of the procedure, we have undertaken controlled experiments on acute hypoventilation.
RESULTS
Greyhounds weighing between 20 and 31 kg were premedicated IM with propiopromazine ( 2 mg/kg) and anesthetized with an intravenous injection of pentobarbital (45 mg/kg).
The dogs were then intubated with cuffed intratracheal tubes and placed on a Harvard respirator. After the intravenous injection of 4 mg/kg of herparin a thin-walled polyvinyl cannula with multiple slits was introduced into a femoral vein and advanced into the thoracic cavity. Through this catheter venous blood was drained by gravity into a pump-oxygenator which had been primed with 1,200 ml Ringer's solution.
Oxygenation of blood was accomplished by the dispersion of small oxygen bubbles through a ceramic microfilter.3 The small amount of oxygen needed to saturate fully even severely hypoxic blood did not create the "dry" foam seen in oxygenators using a high flow or large oxygen bubbles. Although a larger defoaming area was needed to coalesce the small bubbles, the process was devoid of the vigorous bubbling so traumatic to blood. The oxygenated blood was then returned by a pneumatic ventricle pump12 into a jugular vein. Blood flow was monitored by an electromagnetic tlowmeter probe in the venous drainage line. A thennoregulated electrode system was used to measure gas tensions and pH in blood samples withdrawn from a carotid artery and the right ventricle. Cardiac output was measured with the green dye dilution method. Hypoxia was produced by reducing the stroke volume of the respirator. This period obviously could not last long enough to establish a steady state, but was interrupted after a few minutes when two arterial pOz determinations showed similar values.
HYPOVENTILATION mm Hg
In 11 artificially ventilated greyhounds of an average weight of 28 kg the procedure of venovenous pumping without oxygenation of about 1,400 ml of blood per minute was studied first. Since the pulsatile pumping did not affect cardiac output, stroke volume, mean arterial pressure, arterial p 0 2 and pC02, we present the results in graphic form only (Fig 1 ) .
Then acute hypoventilation was produced and pO2, pCO2, pH and buffer base were measured in arterial and venous blood. The same measurements were repeated during venous oxygenation ( Table  1 ). The rate of blood flow through the extracorporeal shunt was kept constant during this period. Hypoventilation produced an average arterial pOz of 45 mm Hg and an average venous p 0 2 of about 20 mm Hg. Extracorporeal oxygenation produced in all instances an increase in venous, ie, right ventricular, and in arterial p02. Due to the short period of hypoventilation only mild hypercarbia developed, and therefore the average arterial and venous pC02 was only slightly reduced during the oxygenation of blood. A bar graph gives a clearer presentation of the marked p 0 2 and the minor pC02 changes (Fig  2) . The changes in pH were correspondingly small. The acidemia before and during venous oxygena-
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% RT. VENTRICULAR BLOOD tion was due to a loss of buffer base (Table 1) . The all pump-oxygenators worthy of that name can increase in venous and in arterial p 0 2 produced by increase the oxygenation of venous blood, the presextracorporeal oxygenation was inversely related to ent study considers the hemodynamic and gas the degree of the previously induced hypoxemia exchange effects separately. In dogs anesthetized (Fig 3 ) .
with sodium pentobarbital, gravity drainage of about arterial pressure or arterial p 0 2 and pC02. In eventual human applications with different anesthetic agents the baroreceptors in the large veins and the right heart may respond to the high pulse pressure of a ventricle pump and changes in flow, pressure and heart rate may occur. The degree of prior hypoventilation evidently defines the extent to which extracorporeal oxygenation can increase the venous p 0 2 . If the gradient between venous and alveolar p 0 2 is small, extracorporeal oxygenation has little to offer and little to accomplish. On the other hand, if the gradient is large, an efficient oxygenator may raise the venous p 0 2 to the alveolar p 0 2 . The extent to which this can be accomplished depends on the rate of blood flow. In our experiments a large, thin-walled catheter with multiple holes shunted about half of the cardiac output from the right atrium into the oxygenator. Knowing t h e hematocrit, t h e p 0 2 , pH a n d temperature of blood entering a n d leaving t h e natural and t h e artificial lung, w e calculated the rate of oxygen transfer of both gas exchangers. T h i s a m o u n t e d t o an average of 140 m l O., per m i n u t e for the lungs a n d 74 m l O2 p e r m i n u t e for the oxygenator. 
